#stem cell

Watch groundbreaking scientists share their experiences and explain how Damon Runyon funding makes a difference in cancer research.

A new study clarifies the benefits and risks of treatments for those with multiple myeloma, a blood cancer more common in Black Americans.

The new—and free—computational tool, CoSpar, integrates two sources of data about a cell.

New discoveries may show a way to save bone marrow cells and blood stem cells following chemotherapy.

New guidelines from NCCN offer clarity and consensus on how best to address and treat a common side effect of stem cell transplants.

Despite being the only current cure for MDS, transplants generally haven’t been offered to older patients.

To find a better FTO-targeting drug, researchers searched a collection of 260,000 chemicals housed by NCI.

The goal is to “make customizable stem cell products that could be adapted to any particular patient.”

The molecule acts specifically against head and neck cancer stem cells, resulting in better tumor control and less toxicity to healthy cells

In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.

Radiation-resistant stem cells take on a major role in muscle repair when regular stem cells are damaged by radiation.

The study suggests that increasing T cells’ exposure to potassium may make cancer immunotherapies more effective.

The technique prevents transplant rejection in the lab, a major advance for stem cell therapies.

Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.

Researchers called the results of treatment using Venclexta (venetoclax) and Vidaza (azacitidine) “remarkably impressive.”

The study used two FDA-approved drugs to the pre-leukemic cells while leaving healthy stem cells alone.